(SYNA) Synaptics - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US87157D1090
Stock: Touch, Display, Biometrics, Wireless, Processor
Total Rating 54
Risk 93
Buy Signal 0.54
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 45.4% |
| Relative Tail Risk | -11.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.52 |
| Alpha | -10.53 |
| Character TTM | |
|---|---|
| Beta | 2.077 |
| Beta Downside | 2.073 |
| Drawdowns 3y | |
|---|---|
| Max DD | 66.78% |
| CAGR/Max DD | -0.16 |
Description: SYNA Synaptics January 13, 2026
Synaptics (NASDAQ:SYNA) designs and sells a broad portfolio of semiconductor solutions-including touch, display, biometric, voice, audio, wireless, and AI/ML-enabled processors-targeting mobile, PC, smart-home, industrial, and automotive markets. Its offerings extend to connectivity modules (Wi-Fi, Bluetooth, Zigbee, Thread, Matter, GPS/GNSS, UWB), display driver ICs, and development kits that integrate software frameworks and AI toolchains. The company distributes products through direct sales, OEM partners, distributors, and value-added resellers, and has been operating since 1986 from its San Jose headquarters.
Key recent metrics: FY2023 revenue reached approximately $1.4 billion, with a 12% year-over-year increase driven largely by automotive and IoT demand; gross margin expanded to 38% as higher-margin AI/ML solutions gained traction. Sector-wide, the semiconductor industry is benefitting from a secular shift toward edge-AI and connected devices, while supply-chain tightening and rising component costs remain material headwinds that could pressure earnings.
For a deeper, data-driven assessment of SYNA’s valuation and risk profile, you may find ValueRay’s analyst framework worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: -61.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 4.52 > 1.0 |
| NWC/Revenue: 44.36% < 20% (prev 65.44%; Δ -21.09% < -1%) |
| CFO/TA 0.08 > 3% & CFO 198.0m > Net Income -61.9m |
| Net Debt (398.6m) to EBITDA (49.9m): 7.99 < 3 |
| Current Ratio: 2.93 > 1.5 & < 3 |
| Outstanding Shares: last quarter (38.9m) vs 12m ago -2.26% < -2% |
| Gross Margin: 43.13% > 18% (prev 0.46%; Δ 4267 % > 0.5%) |
| Asset Turnover: 44.96% > 50% (prev 39.94%; Δ 5.01% > 0%) |
| Interest Coverage Ratio: -71.25 > 6 (EBITDA TTM 49.9m / Interest Expense TTM 800.0k) |
Altman Z'' 2.71
| A: 0.20 (Total Current Assets 771.0m - Total Current Liabilities 263.4m) / Total Assets 2.56b |
| B: 0.45 (Retained Earnings 1.15b / Total Assets 2.56b) |
| C: -0.02 (EBIT TTM -57.0m / Avg Total Assets 2.55b) |
| D: 0.09 (Book Value of Equity 104.0m / Total Liabilities 1.18b) |
| Altman-Z'' Score: 2.71 = A |
Beneish M -3.07
| DSRI: 0.80 (Receivables 132.7m/146.5m, Revenue 1.14b/1.01b) |
| GMI: 1.07 (GM 43.13% / 46.24%) |
| AQI: 1.11 (AQ_t 0.67 / AQ_t-1 0.60) |
| SGI: 1.13 (Revenue 1.14b / 1.01b) |
| TATA: -0.10 (NI -61.9m - CFO 198.0m) / TA 2.56b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of SYNA shares?
As of February 09, 2026, the stock is trading at USD 89.23 with a total of 1,799,243 shares traded.
Over the past week, the price has changed by +4.66%, over one month by +8.17%, over three months by +30.80% and over the past year by +28.48%.
Over the past week, the price has changed by +4.66%, over one month by +8.17%, over three months by +30.80% and over the past year by +28.48%.
Is SYNA a buy, sell or hold?
Synaptics has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy SYNA.
- StrongBuy: 4
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SYNA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 100.4 | 12.5% |
| Analysts Target Price | 100.4 | 12.5% |
| ValueRay Target Price | 94.8 | 6.3% |
SYNA Fundamental Data Overview February 08, 2026
P/E Forward = 20.0401
P/S = 3.1369
P/B = 2.4317
P/EG = 0.4818
Revenue TTM = 1.14b USD
EBIT TTM = -57.0m USD
EBITDA TTM = 49.9m USD
Long Term Debt = 834.8m USD (from longTermDebt, last fiscal year)
Short Term Debt = 12.3m USD (from shortTermDebt, last fiscal year)
Debt = 836.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 398.6m USD (from netDebt column, last quarter)
Enterprise Value = 3.88b USD (3.48b + Debt 836.0m - CCE 437.4m)
Interest Coverage Ratio = -71.25 (Ebit TTM -57.0m / Interest Expense TTM 800.0k)
EV/FCF = 26.80x (Enterprise Value 3.88b / FCF TTM 144.7m)
FCF Yield = 3.73% (FCF TTM 144.7m / Enterprise Value 3.88b)
FCF Margin = 12.64% (FCF TTM 144.7m / Revenue TTM 1.14b)
Net Margin = -5.41% (Net Income TTM -61.9m / Revenue TTM 1.14b)
Gross Margin = 43.13% ((Revenue TTM 1.14b - Cost of Revenue TTM 650.8m) / Revenue TTM)
Gross Margin QoQ = 43.54% (prev 42.60%)
Tobins Q-Ratio = 1.51 (Enterprise Value 3.88b / Total Assets 2.56b)
Interest Expense / Debt = -0.29% (Interest Expense -2.40m / Debt 836.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -45.0m (EBIT -57.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.93 (Total Current Assets 771.0m / Total Current Liabilities 263.4m)
Debt / Equity = 0.60 (Debt 836.0m / totalStockholderEquity, last quarter 1.38b)
Debt / EBITDA = 7.99 (Net Debt 398.6m / EBITDA 49.9m)
Debt / FCF = 2.75 (Net Debt 398.6m / FCF TTM 144.7m)
Total Stockholder Equity = 1.39b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.43% (Net Income -61.9m / Total Assets 2.56b)
RoE = -4.45% (Net Income TTM -61.9m / Total Stockholder Equity 1.39b)
RoCE = -2.56% (EBIT -57.0m / Capital Employed (Equity 1.39b + L.T.Debt 834.8m))
RoIC = -2.02% (negative operating profit) (NOPAT -45.0m / Invested Capital 2.23b)
WACC = 10.90% (E(3.48b)/V(4.32b) * Re(13.57%) + D(836.0m)/V(4.32b) * Rd(-0.29%) * (1-Tc(0.21)))
Discount Rate = 13.57% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.38%
[DCF Debug] Terminal Value 58.41% ; FCFF base≈98.2m ; Y1≈64.4m ; Y5≈29.4m
Fair Price DCF = N/A (negative equity: EV 386.2m - Net Debt 398.6m = -12.4m; debt exceeds intrinsic value)
EPS Correlation: -47.30 | EPS CAGR: -26.04% | SUE: 0.03 | # QB: 0
Revenue Correlation: -58.28 | Revenue CAGR: -11.09% | SUE: 2.62 | # QB: 3
EPS next Quarter (2026-03-31): EPS=1.00 | Chg30d=+0.023 | Revisions Net=+0 | Analysts=13
EPS current Year (2026-06-30): EPS=4.43 | Chg30d=+0.085 | Revisions Net=+6 | Growth EPS=+22.3% | Growth Revenue=+10.6%
EPS next Year (2027-06-30): EPS=5.32 | Chg30d=-0.000 | Revisions Net=+0 | Growth EPS=+20.2% | Growth Revenue=+10.8%
P/S = 3.1369
P/B = 2.4317
P/EG = 0.4818
Revenue TTM = 1.14b USD
EBIT TTM = -57.0m USD
EBITDA TTM = 49.9m USD
Long Term Debt = 834.8m USD (from longTermDebt, last fiscal year)
Short Term Debt = 12.3m USD (from shortTermDebt, last fiscal year)
Debt = 836.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 398.6m USD (from netDebt column, last quarter)
Enterprise Value = 3.88b USD (3.48b + Debt 836.0m - CCE 437.4m)
Interest Coverage Ratio = -71.25 (Ebit TTM -57.0m / Interest Expense TTM 800.0k)
EV/FCF = 26.80x (Enterprise Value 3.88b / FCF TTM 144.7m)
FCF Yield = 3.73% (FCF TTM 144.7m / Enterprise Value 3.88b)
FCF Margin = 12.64% (FCF TTM 144.7m / Revenue TTM 1.14b)
Net Margin = -5.41% (Net Income TTM -61.9m / Revenue TTM 1.14b)
Gross Margin = 43.13% ((Revenue TTM 1.14b - Cost of Revenue TTM 650.8m) / Revenue TTM)
Gross Margin QoQ = 43.54% (prev 42.60%)
Tobins Q-Ratio = 1.51 (Enterprise Value 3.88b / Total Assets 2.56b)
Interest Expense / Debt = -0.29% (Interest Expense -2.40m / Debt 836.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -45.0m (EBIT -57.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.93 (Total Current Assets 771.0m / Total Current Liabilities 263.4m)
Debt / Equity = 0.60 (Debt 836.0m / totalStockholderEquity, last quarter 1.38b)
Debt / EBITDA = 7.99 (Net Debt 398.6m / EBITDA 49.9m)
Debt / FCF = 2.75 (Net Debt 398.6m / FCF TTM 144.7m)
Total Stockholder Equity = 1.39b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.43% (Net Income -61.9m / Total Assets 2.56b)
RoE = -4.45% (Net Income TTM -61.9m / Total Stockholder Equity 1.39b)
RoCE = -2.56% (EBIT -57.0m / Capital Employed (Equity 1.39b + L.T.Debt 834.8m))
RoIC = -2.02% (negative operating profit) (NOPAT -45.0m / Invested Capital 2.23b)
WACC = 10.90% (E(3.48b)/V(4.32b) * Re(13.57%) + D(836.0m)/V(4.32b) * Rd(-0.29%) * (1-Tc(0.21)))
Discount Rate = 13.57% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.38%
[DCF Debug] Terminal Value 58.41% ; FCFF base≈98.2m ; Y1≈64.4m ; Y5≈29.4m
Fair Price DCF = N/A (negative equity: EV 386.2m - Net Debt 398.6m = -12.4m; debt exceeds intrinsic value)
EPS Correlation: -47.30 | EPS CAGR: -26.04% | SUE: 0.03 | # QB: 0
Revenue Correlation: -58.28 | Revenue CAGR: -11.09% | SUE: 2.62 | # QB: 3
EPS next Quarter (2026-03-31): EPS=1.00 | Chg30d=+0.023 | Revisions Net=+0 | Analysts=13
EPS current Year (2026-06-30): EPS=4.43 | Chg30d=+0.085 | Revisions Net=+6 | Growth EPS=+22.3% | Growth Revenue=+10.6%
EPS next Year (2027-06-30): EPS=5.32 | Chg30d=-0.000 | Revisions Net=+0 | Growth EPS=+20.2% | Growth Revenue=+10.8%